Period 3Q13
Actual vs. Expectations
The 3Q13 results came in within
expectations with the 9M13 core earnings of RM300.6m making up 74% and 72% of
our FY13 full-year estimate and that of the market consensus respectively.
Dividends No dividends were declared in 3Q13, the first
time in three years that no quarterly interim dividends were announced. The
company said it is mindful of its cash distribution in the midst of its
STM-Trust listing, which is reasonable in our view. Nonetheless, the 1H13 NDPS
of 16 sen made up 68.5% of the 9M13 earnings, which is not far from its 75%
dividend payout policy.
Key highlights The 3Q13 net profit contracted 24% both QoQ
and YoY to RM86.1m due to a weaker luck factor as the estimated prize payout
ratio (EPPR) inched up to 58.9% in 3Q13 compared to 57.5% in 2Q13 and 58.5% in
3Q12. In addition, the 3Q13 ticket sales weakened by 2% QoQ and 9% YoY as the
average ticket sales per draw at RM21.2m which declined by 2% QoQ (from
RM21.7m) and 7% YoY (from RM22.9m). In 3Q13, 45 draws were conducted, which was
the same as 2Q13, but it was one draw lesser than the 46 draws in 3Q12.
For the YTD, the 9M13
headline net income dropped slightly to RM309.4m from RM310.5m last year while the
top line rose slightly to RM2.70b from RM2.69b. There were 134 draws conducted
during the period as compared to 133 draws last year. The 9M13 EPPR improved
slightly to 58.71% from 58.89% while the average ticket sales were at
RM21.7m/draw from RM21.8m/draw in 9M12. There was also a RM8.8m one-off gain in
1Q13 from the disposal of an unquoted investment, i.e. Cassis International Pte
Ltd.
Outlook Its forward sales/profits remain resilient,
but its net earnings and dividends are set to decline post the listing of
STM-Trust by c.9% and c.20% respectively.
Change to Forecasts
There are no changes to our FY13-FY15
estimates for now. We will adjust our earnings model once the listing of the
Business Trust on SGX-ST is completed.
Rating MAINTAIN UNDERPERFORM
We maintain our view that the spin-off of its NFO business
to be listed as a Business Trust in Singapore may not be value-accretive and
will lead to a derating of the stock by the market.
Valuation Our price target of RM3.88/share is
maintained. This is based on the floor valuation, which includes a 10% holding
company discount to its RNAV and a 49 sen special dividend.
Risks The risks to our estimates are stronger than
exp.
Source: Kenanga
No comments:
Post a Comment